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Background: Blood transfusion has been associated with increased mortality in coronary bypass surgery (CABG). This study examined whether wide 
institutional variation in transfusion rates of red blood cells (RBC), fresh frozen plasma (FFP) and platelets (PLT) could be correlated with operative 
mortality following isolated CABG.
Methods: 31,818 consecutive patients undergoing CABG between January 2006 and June 2010 were entered into a statewide collaborative 
database. RBC, FFP and PLT transfusion rates were determined for all 33 programs. The STS risk calculator was used to determine an observed/
expected mortality ratio (O/E) for each institution. The relationship between hospital-level transfusion rate and mortality was analyzed using simple 
linear regression analysis. P-values and r-square values are reported for each product.
Results: Overall transfusion rates were 55.7% for RBCs (range, 35.9%-84.7%), 14.8% for FFP (4.9%-35.5%) and 19.6 % for PLT (5.8%-36.3%). 
Operative mortality was 2.1% for the entire group (0.5-4.5%). O/E ratios varied from 0.21-1.76. There was no significant relationship between use of 
each blood product and mortality O/E with p-values of 0.78, 0.97 and 0.49 for RBC, FFP and PLT use respectively (Figure). Results were similar for 
intra- and post-op RBC use specifically (p-value 0.64 and 0.96, respectively).
Conclusion: There is great variability in transfusion rates among institutions that perform CABG which does not correlate with risk-adjusted 
operative mortality.
 
